DAVITA INC. DL -,001/ US23918K1088 /
10/11/2024 9:44:17 PM | Chg. +0.550 | Volume | Bid9:59:50 PM | Ask9:59:50 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
146.850EUR | +0.38% | 16 Turnover: 2,346.400 |
146.950Bid Size: 103 | 147.250Ask Size: 103 | 12.34 bill.EUR | - | - |
GlobeNewswire
6/24
BayMark Health Services Announces Leadership Transition: David White Steps Down as CEO; Marshal Salo...
Newsfile Corp
6/18
Healing Realty Trust Closes First Tranche of Series A to Expand Clinic-Focused Portfolio for a New G...
GlobeNewswire
4/26
Benevity’s 2024 Corporate Goodness Awards Celebrate Groundbreakers in Social Impact
GlobeNewswire
11/17/2023
Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial pres...
GlobeNewswire
8/15/2023
Elevar Therapeutics Names Dr. Chris Galloway Vice President of Clinical Development
GlobeNewswire
3/21/2022
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
GlobeNewswire
3/7/2022
The Oncology Institute Announces Promotions for Dr. Daniel Virnich and Dr. Matt Miller
GlobeNewswire
2/10/2022
Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022
GlobeNewswire
10/7/2021
Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Anima...
GlobeNewswire
10/1/2021
AAON Increases Board Size and Appoints Bruce Ware and David Stewart as Independent Directors